Innovative strategies for the elimination of viral hepatitis at a national level: a country case series.

Clicks: 322
ID: 17109
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #5 of 6 articles by views in liver international : official journal of the international association for the study of the liver

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Viral hepatitis is a leading cause of morbidity and mortality worldwide, but has long been neglected by national and international policymakers. Recent modelling studies suggest that investing in the global elimination of viral hepatitis is feasible and cost-effective. In 2016, all 194 member states of the World Health Organization endorsed the goal to eliminate viral hepatitis as a public health threat by 2030, but complex systemic and social realities hamper implementation efforts. This paper presents eight case studies from a diverse range of countries that have invested in responses to viral hepatitis and adopted innovative approaches to tackle their respective epidemics. Based on an investment framework developed to build a global investment case for the elimination of viral hepatitis by 2030, national activities and key enablers are highlighted that showcase the feasibility and impact of concerted hepatitis responses across a range of settings, with different levels of available resources and infrastructural development. These case studies demonstrate the utility of taking a multipronged, public health approach to: (1) evidence-gathering and planning; (2) implementation; and (3) integration of viral hepatitis services into the Agenda for Sustainable Development. They provide models for planning, investment, and implementation strategies for other countries facing similar challenges and resource constraints. This article is protected by copyright. All rights reserved.
Reference Key
schroeder2019innovativeliver Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Schroeder, E Sophia;Pedrana, Alisa;Scott, Nick;Wilson, David;Kuschel, Christian;Aufegger, Lisa;Atun, Rifat;Baptista-Leite, Ricardo;Butsashvili, Maia;El-Sayed, Manal;Getahun, Aneley;Hamid, Saeed;Hammad, Radi;'t Hoen, Ellen;Hutchinson, Sharon J;Lazarus, Jeffrey V;Lesi, Olufunmilayo;Li, Wangsheng;Mohamed, Rosmawati Binti;Olafsson, Sigurdur;Peck, Raquel;Sohn, Annette H;Sonderup, Mark;Spearman, C Wendy;Swan, Tracy;Thursz, Mark;Walker, Tim;Hellard, Margaret;Howell, Jessica;
Journal liver international : official journal of the international association for the study of the liver
Year 2019
DOI
10.1111/liv.14222
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.